Literature DB >> 3369436

Ehrlichiosis: a cause of bone marrow hypoplasia in humans.

C J Pearce1, M E Conrad, P E Nolan, D B Fishbein, J E Dawson.   

Abstract

Infection with Ehrlichia canis should be suspected in patients with fever, headache, malaise, leukopenia, thrombocytopenia, and a history of recent exposure to ticks. The cytopenia is caused by bone marrow hypoplasia which may be severe. The disease may be confused with spotless Rocky Mountain spotted fever but can be differentiated from this infection serologically with acute and convalescent sea. In humans, recovery has occurred with and without antibiotic therapy. However, prompt antibiotic therapy is advised prior to serologic studies, especially in immunocompromised individuals, splenectomized persons, and patients with AIDS-who may develop a more overwhelming rickettsial infection.

Entities:  

Mesh:

Year:  1988        PMID: 3369436     DOI: 10.1002/ajh.2830280111

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  10 in total

1.  Canine ehrlichiosis in Connecticut.

Authors:  L A Magnarelli; H J Litwin; C J Holland; J F Anderson; M Ristic
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

2.  Epidemiologic and clinical characteristics of persons with serologic evidence of E. canis infection.

Authors:  B W Rohrbach; J R Harkess; S A Ewing; J Kudlac; G L McKee; G R Istre
Journal:  Am J Public Health       Date:  1990-04       Impact factor: 9.308

3.  Downregulation of CXCL12 signaling and altered hematopoietic stem and progenitor cell trafficking in a murine model of acute Anaplasma phagocytophilum infection.

Authors:  J L Johns; D L Borjesson
Journal:  Innate Immun       Date:  2011-09-29       Impact factor: 2.680

4.  Lack of co-transmission of Rickettsia conorii and Ehrlichia canis in human beings in the south of France.

Authors:  P Brouqui; D Raoult; E Vidor
Journal:  Eur J Epidemiol       Date:  1989-03       Impact factor: 8.082

5.  In vitro antibiotic susceptibility of the newly recognized agent of ehrlichiosis in humans, Ehrlichia chaffeensis.

Authors:  P Brouqui; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

6.  Defining the immune response to Ehrlichia species using murine models.

Authors:  Stephen K Chapes; Roman R Ganta
Journal:  Vet Parasitol       Date:  2008-10-17       Impact factor: 2.738

7.  Immunosuppression in Experimental Chagas Disease Is Mediated by an Alteration of Bone Marrow Stromal Cell Function During the Acute Phase of Infection.

Authors:  Uwe Müller; Günter A Schaub; Horst Mossmann; Gabriele Köhler; Rita Carsetti; Christoph Hölscher
Journal:  Front Immunol       Date:  2018-12-10       Impact factor: 7.561

8.  Molecular evidence supporting Ehrlichia canis-like infection in cats.

Authors:  Edward B Breitschwerdt; Anthony C G Abrams-Ogg; Michael R Lappin; Dorothee Bienzle; Susan I Hancock; Sara M Cowan; Jennifer K Clooten; Barbara C Hegarty; Eleanor C Hawkins
Journal:  J Vet Intern Med       Date:  2002 Nov-Dec       Impact factor: 3.333

Review 9.  Hematopoietic Stem Cell Regulation by Type I and II Interferons in the Pathogenesis of Acquired Aplastic Anemia.

Authors:  Julianne N P Smith; Vikramjit S Kanwar; Katherine C MacNamara
Journal:  Front Immunol       Date:  2016-08-29       Impact factor: 7.561

10.  Type I IFNs drive hematopoietic stem and progenitor cell collapse via impaired proliferation and increased RIPK1-dependent cell death during shock-like ehrlichial infection.

Authors:  Julianne N P Smith; Yubin Zhang; Jing Jing Li; Amanda McCabe; Hui Jin Jo; Jackson Maloney; Katherine C MacNamara
Journal:  PLoS Pathog       Date:  2018-08-06       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.